Time to heart decompensation · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Disease‐free period at 30, 60 and 90 days · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Quality of life · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Adverse events · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Hospital readmissions (heart failure‐ or adverse event‐related) · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Cardiac mortality · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Time to heart decompensation · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Disease‐free period at 30, 60 and 90 days · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Overall survival · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Quality of life · heart failure in patients with Chagas cardiomyopathy
1 finding from 1 review
Adverse events · heart failure in patients with Chagas cardiomyopathy
It is very uncertain whether carvedilol changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Cardiac mortality · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Incidence of pain with lidocaine pretreatment Pain scales · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Lidocaine may leads to lower pain ‐ lidocaine compared with placebo (low certainty).
1 finding from 1 review
Pain ‐ fentanyl · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Fentanyl may leads to lower pain ‐ fentanyl compared with placebo (low certainty).
1 finding from 1 review
Pain ‐ remifentanil · adults and children undergoing general anaesthesia including the muscle relaxant rocuronium bromide
Remifentanil may leads to lower pain ‐ remifentanil compared with placebo (low certainty).
1 finding from 1 review
Indirect measure of spasticity Modified Ashworth Scale · people with spasticity following stroke
It is very uncertain whether systemic antispasticity drugs changes indirect measure of spasticity Modified Ashworth Scale compared with placebo (very low certainty).
1 finding from 1 review
Adverse events Adverse events per participant · people with spasticity following stroke
It is very uncertain whether systemic antispasticity drugs changes adverse events Adverse events per participant compared with placebo (very low certainty).
1 finding from 1 review
Sleepiness during the day shift · Shift workers
1 finding from 1 review
Quality of sleep · Shift workers
1 finding from 1 review